Medicines are a gift to the world. But take too much of it, and it will backfire.It has been hotly debated that taking unmonitored doses of over-the-counter (OTC) drugs can cause harmful side effects...
The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto...
The FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 10-1 in favor of approval for vorapaxar, Merck's novel thrombin receptor antagonist. The “roller coaster ride” cliché might have...
The much awaited Consumer Electronics Show (CES), also known as International CES is just only a few days away from now. We have been eagerly waiting for this event since last and can’t wait anymore...
Today, Illumina, the leading maker of DNA sequencers, announced a milestone in biotechnology: it is introducing a new machine that can sequence the genetic code of a human cell for $1,000. The...
Diabetes is a disease that requires many of those who suffer from it to check their blood sugar regularly. A new glucometer has turned up that makes it easy to keep track of those readings using your...
It didn’t seem possible but the guideline situation just got even more confusing. Last December, after years of delay and other twists and turns, the Eighth Joint National Committee (JNC 8)...
A few years ago a novel antiplatelet agent from Merck seemed all but dead. Vorapaxar, a thrombin receptor antagonist, was widely thought to have no future after unacceptably high serious bleeding...
RxAnte, which applies predictive analytics to medication adherence, became part of Millennium Laboratories in December. The companies are mum on details of the sale. Aberdare Ventures partner...
The much awaited Consumer Electronics Show (CES), also known as International CES is just only a few days away from now. We have been eagerly waiting for this event since last and can’t wait anymore...